Michele Liuzzi
Corporate Officer/Principal at IDENIX PHARMACEUTICALS INC
Michele Liuzzi active positions
Companies | Position | Start | End |
---|---|---|---|
IDENIX PHARMACEUTICALS INC | Corporate Officer/Principal | - | - |
Boehringer Ingelheim (Canada) Ltd.
Boehringer Ingelheim (Canada) Ltd. BiotechnologyHealth Technology Boehringer Ingelheim (Canada) Ltd. engages in the research and development of new drugs and medicines for the treatment of respiratory diseases. The firm offers therapeutic options for diseases and conditions, such as chronic obstructive pulmonary disease, high blood pressure, stroke, depression, benign prostatic hyperplasia, Parkinson's disease, virology, stroke prevention in atrial fibrillation, and diabetes. The company was founded in 1972 and is headquartered in Burlington, Canada. | Corporate Officer/Principal | - | - |
Career history of Michele Liuzzi
Former positions of Michele Liuzzi
Companies | Position | Start | End |
---|---|---|---|
Institut Pasteur Korea Research Foundation
Institut Pasteur Korea Research Foundation BiotechnologyHealth Technology Institut Pasteur Korea Research Foundation provides research and development for the treatment of infectious and chronic diseases. It develops a technology-based approach to therapeutic development through cellular models, high content screening and medicinal chemistry. The company was founded on December 29, 2003 and is headquartered in Seongnam, South Korea. | Director/Board Member | - | - |
Chief Executive Officer | - | - |
Training of Michele Liuzzi
University of Liege | Doctorate Degree |
Statistics
International
United States | 2 |
Belgium | 2 |
South Korea | 2 |
Operational
Corporate Officer/Principal | 2 |
Director/Board Member | 1 |
Chief Executive Officer | 1 |
Sectoral
Health Technology | 4 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 3 |
---|---|
Idenix Pharmaceuticals LLC
Idenix Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Idenix Pharmaceuticals LLC is a biopharmaceutical company, which is engaged in the discovery and development of drugs for the treatment of human viral diseases with operations in the United States and France. Currently, its primary research and development focus is on the treatment of patients with hepatitis C virus, or HCV, using nucleotide polymerase inhibitors and NS5A inhibitors. Idenix Pharmaceuticals was founded by Jean-Pierre Sommadossi and Raymond F. Schinazi in May 1998 and is headquartered in Cambridge, MA. | Health Technology |
Institut Pasteur Korea Research Foundation
Institut Pasteur Korea Research Foundation BiotechnologyHealth Technology Institut Pasteur Korea Research Foundation provides research and development for the treatment of infectious and chronic diseases. It develops a technology-based approach to therapeutic development through cellular models, high content screening and medicinal chemistry. The company was founded on December 29, 2003 and is headquartered in Seongnam, South Korea. | Health Technology |
Boehringer Ingelheim (Canada) Ltd.
Boehringer Ingelheim (Canada) Ltd. BiotechnologyHealth Technology Boehringer Ingelheim (Canada) Ltd. engages in the research and development of new drugs and medicines for the treatment of respiratory diseases. The firm offers therapeutic options for diseases and conditions, such as chronic obstructive pulmonary disease, high blood pressure, stroke, depression, benign prostatic hyperplasia, Parkinson's disease, virology, stroke prevention in atrial fibrillation, and diabetes. The company was founded in 1972 and is headquartered in Burlington, Canada. | Health Technology |
- Stock Market
- Insiders
- Michele Liuzzi
- Experience